Navigation Links
Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
Date:4/2/2013

Boston, MA (PRWEB) April 02, 2013

Cambridge Semantics will again be a featured presenter at the annual Bio-IT World Conference & Expo. During this month’s event, Cambridge Semantics Vice President of Marketing and Technology, Lee Feigenbaum will speak on a new conference track, “Data Visualization and Exploration” which highlights novel visualization approaches that address important challenges in genomic data, networks, microscopy, imaging and the support of discovery, clinical and translational research. During his session, Mr. Feigenbaum will address Unified Information Access and its role in data exploration and visualization. To learn more visit http://www.bio-itworldexpo.com or visit the Cambridge Semantics booth #129 at the event.

Featured presentation:

  •     Date and time: Wednesday, April 10th at 12:00 p.m. EST
  •     Title: Whence the Data? The Importance of Feeding the Right Data to Your Visualizations
  •     Session description: Visualizations are only as good as the data that drives them.
Frequently, the right data comes from many and diverse sources. This discussion will present the case for Unified Information Access, a paradigm that lets you easily combine structured and unstructured data from inside and outside your organization in support of ever-evolving data exploration and visualization. Examples will include practical applications for competitive intelligence, safety, and assay data management.

In addition, Cambridge Semantics executives will be onsite at booth #129 demonstrating the company’s Competitive Intelligence and Drug Safety & Pharmacovigilance solutions. At the 2012 Bio-IT World Conference Cambridge Semantics’ Competitive Intelligence Solution was named “Best of Show” for its unique approach to helping pharma companies handle their diverse and ever-changing information needs. The company’s Drug Safety & Pharmacovigilance solution helps pharma reduce operational cost and improve risk management by automating and streamlining the process of discovering, managing, and analyzing adverse drug reactions.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10589552.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
2. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
3. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
4. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
5. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
6. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
7. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
8. Clinverse CEO to Speak at MAGI East 2013
9. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
10. iLuv Introducing NFC & Qi-Certified Technology to Bluetooth Speaker Lineup at 2013 CES
11. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):